cem
jurkat
cell
obtain
atcc
manassa
va
maintain
roswel
park
memori
institut
rpmi
media
contain
heatinactiv
fetal
bovin
serum
fb
lglutamin
streptomycinpenicillin
qualiti
biolog
gaithersburg
md
cell
clone
hela
cell
sustain
dulbecco
modifi
eagl
medium
dmem
contain
heatinactiv
fetal
bovin
serum
fb
lglutamin
streptomycinpenicillin
qualiti
biolog
peripher
blood
mononuclear
cell
pbmc
maintain
rpmi
media
contain
fb
lglutamin
streptomycinpenicillin
pbmc
also
maintain
iuml
human
recombin
interleukin
il
sigma
transfect
incub
absenc
exogen
growth
factor
transfect
cell
incub
antibiot
select
transfect
cell
hygromycin
b
invitrogen
ad
cultur
next
day
inhibitor
fascaplysin
abcam
ribociclib
medchemexpress
use
treatment
clone
cell
cultur
analysi
cyclin
inhibit
cell
viabil
ev
product
ebov
mayinga
isol
express
plasmid
invitrogen
cytomegaloviru
cmv
promot
specif
antibiot
select
marker
twenti
microgram
escherichia
colipurifi
dna
transfect
cell
use
electropor
previous
describ
transfect
cell
treat
next
day
hygromycin
b
plasmid
select
gener
resist
clone
transfect
cell
cultur
week
follow
isol
surviv
coloni
multipl
passag
specif
antibiot
select
total
new
resist
clone
gener
produc
vari
amount
select
clone
shown
supplementari
figur
two
clone
intermedi
high
clone
select
complement
exist
low
clone
previous
publish
clariti
renam
clone
clone
low
wherea
design
medium
high
clone
clone
intermedi
clone
high
respect
resist
clone
kept
constant
hygromycin
b
antibiot
select
transfect
cell
hela
cell
pbmc
perform
logphas
cell
attracten
reagent
qiagen
accord
manufactur
instruct
brief
logphas
cell
incub
transfect
complex
form
plasmid
dna
attracten
reagent
serumfre
media
cell
complex
incub
day
follow
analysi
cell
viabil
celltiterglo
assay
nanotrap
nt
particl
use
provid
cere
nanosci
inc
describ
detail
previous
brief
nt
particl
highli
porou
multifunct
hydrogel
particl
approxim
nm
diamet
compos
highaffin
aromat
dye
compound
coval
link
interior
hydrogel
particl
structur
particl
use
frequent
laboratori
includ
particl
cere
contain
reactiv
red
core
bait
particl
cere
cibacron
blue
particl
type
nipambisaa
matrix
shell
lack
vinyl
sulfon
acid
captur
isol
ev
cell
cultur
supernat
slurri
particl
cere
nanosci
incub
ml
cellfre
filter
supernat
sampl
bound
hour
nt
pellet
isol
wash
steril
phosphatebuff
salin
pb
without
calcium
magnesium
follow
prepar
downstream
assay
western
blot
analysi
wash
nt
pellet
resuspend
laemmli
buffer
load
onto
trisglycin
sodium
dodecyl
sulfat
sd
gel
analysi
character
vlp
vlp
contain
ebov
np
gp
produc
insect
cell
recombin
baculoviru
infect
use
obtain
ibt
bioservic
analysi
vlp
passag
filter
vlp
spike
ml
steril
pb
follow
filtrat
alongsid
pb
control
result
filtrat
incub
particl
slurri
overnight
nt
pellet
use
next
day
sdspolyacrylamid
gel
electrophoresi
page
western
blot
analysi
presenc
ebov
protein
analysi
vlp
comparison
ev
distribut
upon
passag
size
exclus
fraction
filtrat
vlp
spike
ml
supernat
produc
exosomefre
media
supernat
either
filter
filter
directli
incub
exomax
opti
enhanc
reagentfilt
supernat
system
bioscienc
overnight
concentr
ev
extracellular
vesicl
pellet
resuspend
ml
steril
pb
load
onto
qevorigin
size
exclus
column
izon
accord
manufactur
instruct
fraction
number
ml
collect
incub
slurri
overnight
result
nt
pellet
resuspend
laemmli
buffer
sdspage
western
blot
analysi
ebov
protein
exosom
marker
level
extracellular
vesicl
obtain
ebovinfect
cell
cultur
biosafeti
level
bsl
condit
human
umbil
vein
endotheli
cell
huvec
infect
ebov
multipl
infect
moi
incub
day
two
millilit
supernat
harvest
pass
filter
incub
exomax
reagentfilt
supernat
reagent
overnight
concentr
ev
extracellular
vesicl
pellet
resuspend
ml
steril
pb
load
onto
qevorigin
size
exclus
column
accord
manufactur
instruct
purifi
vesicl
collect
fraction
number
fraction
incub
slurri
room
temperatur
hour
extracellular
vesiclebound
nt
wash
pb
resuspend
nupag
ld
sampl
buffer
thermo
fisher
sdspage
western
blot
analysi
ebov
protein
level
sampl
heat
minut
twice
electrophoresi
captur
isol
ev
inactiv
gamma
irradi
rhesu
monkey
macaca
mulatta
serum
sampl
obtain
us
armi
medic
research
institut
infecti
diseas
serum
anim
n
ebov
dilut
steril
pb
without
calcium
magnesium
pass
filter
sampl
incub
slurri
hour
nt
pellet
wash
steril
pb
without
calcium
magnesium
resuspend
laemmli
buffer
western
blot
analysi
exosom
marker
protein
nonhuman
primat
detail
follow
nhp
day
preble
serum
nhp
ebov
pool
serum
day
postinfect
pi
anim
die
day
nhp
ebov
pool
serum
day
pi
anim
die
day
experi
involv
nhp
inactiv
ebov
sampl
carri
institut
biosafeti
committeeapprov
institut
biosafeti
guidelin
perform
level
cell
either
plate
fb
dmem
block
hydroxyurea
day
preblock
hydroxyurea
hour
mm
final
concentr
sigma
cell
place
fresh
dmem
hour
follow
addit
nocodazol
ngml
sigma
day
block
cell
either
imag
evo
xl
core
imag
system
life
technolog
subsequ
assay
cell
viabil
harvest
lyse
use
downstream
western
blot
analysi
extracellular
vesicl
block
cell
obtain
day
incub
exosomefre
media
isol
particl
extracellular
vesiclebound
particl
use
either
western
blot
acetylcholinesteras
ach
assay
zetaview
analysi
cell
seed
plate
cell
per
well
fresh
media
follow
treatment
well
plate
treat
triplic
treatment
cem
jurkat
cell
cell
cultur
supernat
control
cell
resist
clone
cultur
day
exosomefre
media
maxim
ev
concentr
within
media
previous
describ
media
harvest
cell
centrifug
minut
remov
cell
cellular
debri
filter
seed
cell
fresh
media
total
treat
supernat
treatment
cem
jurkat
cell
incub
day
follow
measur
cell
viabil
use
celltiterglo
cell
luminesc
viabil
kit
promega
madison
wi
per
manufactur
instruct
brief
celltiterglo
reagent
ad
well
reagentcel
suspens
plate
shaken
minut
incub
room
temperatur
minut
follow
detect
luminesc
use
glomax
explor
multidetect
system
promega
viabil
analysi
cell
cycl
block
cell
seed
describ
starvat
well
plate
fresh
fb
dmem
wherea
other
fb
dmem
cell
treat
either
hydroxyurea
mm
nocodazol
ngml
cell
receiv
nocodazol
treatment
pretreat
hour
hydroxyurea
mm
note
hydroxyurea
normal
use
mm
block
cell
test
higher
concentr
block
cell
without
cell
death
cell
incub
day
follow
measur
cell
viabil
use
celltiterglo
assay
describ
cell
pellet
harvest
wash
twice
pb
without
calcium
magnesium
resuspend
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
nonidet
mm
naf
mm
mm
dithiothreitol
dtt
complet
proteas
inhibitor
mixtur
ml
roch
appli
scienc
suspens
incub
ice
minut
gentl
vortex
everi
minut
follow
centrifug
minut
protein
concentr
lysat
supernat
quantifi
use
bradford
protein
assay
accord
manufactur
instruct
biorad
prepar
ebovinfect
huvec
lysat
perform
previous
describ
infect
huvec
fix
neutralbuff
formalin
plate
fix
huvec
monolay
wash
pb
solut
mm
tri
ph
contain
sd
ad
cell
scrape
transfer
polypropylen
tube
sampl
heat
minut
hour
excess
sd
dialyz
use
spin
filtrat
protein
content
determin
bca
assay
western
blot
analysi
wholecel
extract
resuspend
laemmli
buffer
heat
minut
load
onto
trisglycin
sd
gel
nt
particl
pellet
resuspend
laemmli
buffer
heat
minut
vortex
time
fulli
resuspend
elut
materi
load
onto
trisglycin
gel
gel
run
maximum
v
wettransf
overnight
onto
polyvinyliden
difluorid
pvdf
membran
membran
block
milk
pb
contain
tween
hour
incub
overnight
appropri
primari
antibodi
adpribos
e
histon
deacetylas
santa
cruz
biotechnolog
abcam
system
bioscienc
cell
signal
ibt
bioservic
extracellular
vesicl
ebovinfect
huvec
lysat
ebovinfect
cell
drytransf
pvdf
membran
iblot
system
thermo
fisher
np
detect
describ
wherea
gp
detect
murin
monoclon
ebov
gpspecif
antibodi
membran
incub
appropri
horseradish
peroxidas
hrp
conjug
secondari
antibodi
hour
develop
use
clariti
clariti
max
western
ecl
substrat
biorad
luminesc
visual
chemidoc
touch
imag
system
biorad
laboratori
substanti
experi
isol
prepar
exosom
ev
character
function
analysi
particularli
context
viral
infect
experi
use
cell
clone
grown
exosomefre
dmem
contain
heatinactiv
fb
ultracentrifug
minut
remov
vesicl
lglutamin
streptomycinpenicillin
qualiti
biolog
exosom
prepar
made
exosomefre
cell
cultur
supernat
filter
produc
fulli
confluent
cell
grown
day
isol
exosom
western
blot
analysi
ach
assay
particl
use
describ
character
exosom
gradient
separ
western
blot
ml
unfilt
cell
cultur
supernat
incub
ml
exomax
opti
enhanc
overnight
vesicl
pellet
spun
minut
resuspend
steril
pb
without
calcium
magnesium
resuspend
vesicl
place
top
iodixanol
optiprep
sigma
gradient
prepar
pb
increment
rang
gradient
ultracentrifug
minut
ti
rotor
beckman
gradient
fraction
collect
top
gradient
increment
transfer
steril
microcentrifug
tube
separ
iodixanol
fraction
incub
slurri
overnight
follow
process
western
blot
ms
analysi
altern
select
iodixanol
fraction
pool
resuspend
steril
pb
follow
ultracentrifug
minut
rotor
beckman
pellet
ev
remov
iodixanol
downstream
function
assay
direct
isol
ev
small
volum
cellfre
supernat
cell
grown
exosomefre
media
complet
ultracentrifug
minut
rotor
beckman
result
ev
pellet
resuspend
steril
pb
use
zetaview
analysi
subsequ
function
assay
ach
protein
level
exosom
determin
fluorocet
ultrasensit
exosom
quantit
assay
kit
system
bioscienc
follow
manufactur
instruct
brief
neg
control
contain
buffer
solut
exosom
neg
standard
curv
prepar
nanoparticl
pellet
sampl
filter
cell
cultur
media
plate
treat
fluoresc
correspond
ach
activ
measur
glomax
explor
multidetect
system
promega
number
exosom
calcul
use
standard
curv
nanoparticl
track
analysi
nta
perform
use
zetaview
znta
particl
metrix
correspond
softwar
zetaview
one
hundr
nanomet
polystyren
nanostandard
particl
appli
microspher
use
calibr
instrument
sampl
read
sensit
minimum
bright
autom
qualiti
control
measur
includ
limit
cell
qualiti
check
instrument
align
focu
also
perform
use
zetaview
sampl
measur
measur
instrument
preacquisit
paramet
set
temperatur
sensit
frame
rate
frame
per
second
shutter
speed
sampl
ml
sampl
dilut
deioniz
water
load
cell
instrument
measur
sampl
differ
posit
throughout
cell
cycl
read
posit
autom
analysi
remov
outlier
posit
mean
median
mode
indic
diamet
size
concentr
sampl
calcul
machin
softwar
measur
data
zetaview
analyz
use
correspond
softwar
zetaview
microsoft
excel
select
mode
defin
size
abund
particl
measur
size
analysi
cytoplasm
nuclear
compart
isol
extract
use
neper
nuclear
cytoplasm
extract
reagent
kit
thermo
fisher
scientif
accord
manufactur
instruct
brief
logphas
cell
harvest
wash
pb
incub
ice
cold
cer
sampl
vortex
second
incub
ice
minut
next
ice
cold
cer
ii
ad
sampl
vortex
second
incub
ice
minut
tube
vortex
spun
minut
follow
transfer
cytoplasm
fraction
clean
prechil
tube
insolubl
nuclei
pellet
suspend
ice
cold
ner
vortex
second
incub
ice
minut
addit
vortex
everi
minut
sampl
centrifug
minut
result
nuclear
fraction
transfer
clean
prechil
tube
result
fraction
analyz
protein
concentr
bradford
assay
biorad
use
sdspage
subsequ
western
blot
analysi
peptid
kinas
assay
perform
describ
previous
brief
immunoprecipit
ip
perform
incub
wholecel
extract
appropri
primari
antibodi
rabbit
immnunoglobulin
ig
g
santa
cruz
biotechnolog
ml
hour
next
day
complex
precipit
slurri
ag
bead
calbiochem
hour
wash
twice
kinas
buffer
phosphoryl
reaction
perform
ipe
materi
appropri
peptid
abclon
scienc
atp
substrat
ttk
kinas
buffer
contain
mm
hepe
ph
mm
mm
egta
mm
dtt
sampl
also
incub
inhibitor
fascaplysin
abcam
reaction
mixtur
contain
follow
final
concentr
mm
ph
mm
egta
glycerol
adenosin
triphosph
atp
mm
mm
naf
mm
orthovanad
vv
reaction
incub
hour
sampl
dot
onto
whatman
glass
microfib
filter
dri
minut
subsequ
submerg
te
buffer
gentl
agit
hour
sampl
quantifi
use
scintil
counter
quantasmart
cpm
assay
count
logphas
cell
cell
harvest
process
chromatin
ip
chip
cyclin
promot
pcr
use
imprint
chromatin
immunoprecipit
kit
sigma
accord
manufactur
instruct
brief
sampl
crosslink
use
formaldehyd
incub
hour
follow
quench
glycin
cell
suspensionglycin
sampl
sonic
use
ip
pol
ii
santa
cruz
ibt
bioservic
overnight
next
day
slurri
ag
bead
calbiochem
ad
incub
hour
sampl
wash
ip
wash
buffer
sigma
addit
proteinas
k
unitsml
incub
revers
solut
sigma
ad
sampl
incub
addit
minut
dna
purifi
quantit
pcr
analysi
perform
undilut
aliquot
dna
use
sybr
green
biorad
follow
pair
primer
amplifi
cyclin
promot
region
contain
rna
pol
ii
start
site
cyclin
cac
ttc
gca
gca
cag
tm
cyclin
cgg
act
aca
ggg
gca
tm
serial
dilut
dna
cell
use
quantit
standard
pcr
condit
follow
cycl
minut
follow
cycl
minut
cycl
second
second
absolut
quantif
sampl
determin
base
cycl
threshold
valu
rel
standard
curv
quantit
pcr
reaction
carri
triplic
use
real
time
system
biorad
ev
nt
particleprocess
iodixanol
fraction
describ
treat
urea
dtt
lyse
vesicl
sampl
reduc
mm
dtt
alkyl
mm
iodoacetamid
sampl
next
dilut
solut
equal
part
water
mm
follow
trypsin
promega
digest
hour
sampl
centrifug
room
temperatur
minut
supernat
collect
microcentrifug
tube
ziptip
use
collect
peptid
sampl
dri
resuspend
trifluoroacet
acid
solut
load
orbitrap
fusion
mass
spectromet
bioinformat
search
swissprot
use
identifi
peptid
labelfre
precursor
ion
detect
method
proteom
discover
version
thermo
fisher
scientif
use
accur
mass
measur
protein
peptid
specif
retent
time
precursor
fragment
cell
cultur
exosomefre
dmem
day
follow
harvest
filter
supernat
ten
millilit
supernat
sampl
incub
exomax
overnight
spun
resuspend
separ
optiprep
iodixanol
gradient
describ
iodixanol
fraction
cell
type
combin
use
sidebysid
unprocess
cell
supernat
filter
analysi
cytokin
profil
whole
supernat
versu
associ
exosom
human
cytokin
array
membran
abcam
use
accord
manufactur
instruct
brief
membran
block
room
temperatur
minut
follow
incub
sampl
overnight
gentl
rock
next
day
sampl
aspir
membran
wash
subsequ
incub
overnight
biotinconjug
membran
wash
incub
hrpconjug
streptavidin
hour
room
temperatur
wash
detect
chemiluminesc
accomplish
via
chemidoc
touch
imag
system
biorad
raw
densitometri
count
obtain
use
imagej
softwar
exposur
match
cytokin
membran
accord
posit
control
signal
densitometri
data
normal
subtract
background
repres
neg
control
membran
standard
deviat
calcul
quantit
experi
done
triplic
p
valu
calcul
use
student
test
microsoft
excel
consid
statist
signific
p
previou
work
use
stabli
transfect
clone
cell
line
name
see
method
show
packag
exosom
therebi
impact
recipi
cell
verifi
find
transfect
new
seri
cell
ebov
plasmid
treat
hygromycin
b
plasmid
select
week
cultur
constant
antibiot
select
surviv
coloni
total
clone
isol
cultur
day
ev
particl
incub
western
blot
analysi
level
exosom
marker
result
supplementari
figur
show
repres
panel
result
clone
line
produc
similar
level
ev
western
blot
analysi
howev
line
produc
lower
higher
level
respect
comparison
rest
clone
still
exhibit
higher
level
exosom
marker
alix
actin
find
indic
clone
may
produc
higher
level
ev
differenti
amount
packag
compar
sidebysid
preexist
line
produc
low
level
extracellular
produc
intermedi
level
wherea
releas
high
level
ev
data
shown
reason
chose
line
util
futur
experi
determin
dose
depend
donor
recipi
cell
respons
process
gener
clone
observ
notabl
acceler
growth
cell
produc
data
shown
well
document
mani
virus
includ
human
immunodefici
viru
type
human
cytomegaloviru
human
tcell
leukemia
viru
type
epsteinbarr
viru
ebv
human
papillomavirus
hpv
kaposi
sarcoma
herpesviru
hepat
b
viru
hepat
c
viru
adenovirus
influenza
virus
infecti
bronchiti
viru
infect
cell
alter
cell
cycl
benefit
viral
replic
therefor
ask
whether
similar
phenotyp
occur
within
clone
address
question
block
control
cell
stage
cell
cycl
either
day
observ
chang
cell
morpholog
viabil
figur
data
figur
show
day
cell
cycl
block
cell
type
expect
morpholog
minim
cell
death
specif
cell
appear
adher
stretch
cell
adher
enlarg
wherea
cell
smaller
round
result
correspond
cell
viabil
assay
figur
indic
block
cell
reduc
viabil
would
also
expect
function
cell
cycl
block
day
differ
pattern
cell
type
observ
control
cell
retain
similar
phenotyp
day
compar
day
howev
note
signific
cell
death
observ
cell
day
figur
contrast
donor
cell
express
greater
cell
viabil
line
increas
amount
produc
figur
strikingli
increas
level
produc
cell
adher
less
expect
phenotyp
exhibit
cell
day
cell
viabl
compar
cell
clump
togeth
form
structur
close
resembl
viral
synaps
figur
similar
seen
virus
japanes
enceph
viru
influenza
viru
possibl
clump
structur
may
repres
potenti
synapt
mechan
use
ebov
epitheli
cell
infect
nutrient
deplet
cell
cycl
hinder
addit
cell
continu
slip
cell
cycl
block
especi
cell
demonstr
mani
round
cell
present
cultur
mani
adher
cell
cultur
figur
pattern
demonstr
increas
cell
viabil
cell
compar
figur
final
regardless
length
incub
product
leveldepend
increas
number
viabil
control
cell
compar
support
previou
observ
increas
growth
rate
cell
taken
togeth
result
indic
cell
produc
may
acceler
rate
growth
directli
proport
amount
produc
furthermor
cell
may
potenti
abl
push
past
cell
cycl
block
impos
extern
intern
influenc
indic
dysregul
cell
cycl
checkpoint
result
increas
surviv
variou
environment
stress
cell
observ
acceler
growth
next
explor
effect
product
level
cyclin
cdk
protein
western
blot
analysi
cyclin
cdk
level
cell
show
level
increas
cell
wherea
cyclin
e
show
small
upregul
increas
produc
figur
cyclin
initi
increas
low
level
decreas
dosedepend
manner
increas
level
produc
hand
cyclin
increas
dosedepend
manner
increas
level
cyclin
previous
shown
result
acceler
cell
cycl
mani
type
oncogen
phenotyp
addit
sever
virus
includ
hpv
ebv
human
neurotrop
jc
viru
human
respiratori
syncyti
viru
previous
shown
influenc
level
cyclin
infect
cell
aid
viral
life
cycl
cyclin
primari
role
cell
cycl
bind
cdk
partner
activ
kinas
activ
therebi
phosphoryl
substrat
rb
induc
cell
cycl
progress
phase
therefor
investig
abil
cyclin
cell
initi
phosphoryl
substrat
rb
residu
two
peptid
gener
one
peptid
map
cyclin
phosphoryl
site
rb
one
peptid
point
mutat
control
wholecel
extract
immunoprecipit
igg
precipit
complex
incub
either
peptid
incub
fascaplysin
inhibitor
vitro
kinas
assay
perform
use
atp
result
figur
show
cell
activ
cyclin
complex
phosphoryl
peptid
expect
wherea
peptid
peptid
incub
fascaplysin
minim
background
level
phosphoryl
interest
note
cell
increas
level
phosphoryl
ipe
cyclin
compar
cell
moreov
incub
fascaplysin
complet
amelior
cyclin
activ
peptid
taken
togeth
result
indic
cyclin
higher
level
activ
cell
compar
cell
inhibit
activ
cyclin
complex
cell
fascaplysin
less
effect
find
could
perhap
due
overal
greater
amount
cyclin
present
cell
therefor
higher
concentr
fascaplysin
may
need
prevent
kinas
activ
base
upon
observ
acceler
growth
increas
level
cyclin
cell
produc
next
wish
investig
potenti
factor
contribut
cyclin
transcript
previou
studi
shown
intrigu
presenc
ebov
within
nucleu
especi
earli
time
point
infect
confirm
presenc
nuclear
compart
clone
cytoplasm
nuclear
fraction
cell
isol
neper
nuclear
cytoplasm
extract
kit
cytoplasm
protein
escrtiii
compon
nuclear
protein
involv
chromatin
remodel
use
control
cytoplasm
nuclear
compart
respect
actin
also
use
measur
even
load
sampl
actin
shown
abundantli
present
cytoplasm
nucleu
result
figur
show
protein
present
cytoplasm
nucleu
cell
surpris
find
level
nuclear
fraction
nearli
equival
seen
cytoplasm
compart
repres
much
higher
proport
nuclear
anticip
therefor
hypothes
may
potenti
act
transcript
factor
cyclin
promot
elicit
increas
level
cyclin
therebi
acceler
growth
host
cell
rna
polymeras
ii
pol
ii
found
promot
activ
transcrib
gene
previous
shown
involv
activ
transcript
cyclin
mitogeninduc
gene
involv
cell
growth
differenti
along
line
ascertain
whether
pol
ii
potenti
involv
transcript
upregul
cyclin
perform
chip
analysi
cyclin
promot
cell
data
figur
show
cell
background
level
pol
ii
dna
input
respect
background
level
particularli
may
partial
attribut
nonspecif
bind
protein
ip
procedur
chip
interestingli
pol
ii
cyclin
promot
doubl
wherea
increas
dna
input
cell
even
surpris
present
cyclin
promot
cell
astound
dna
input
collect
data
suggest
pol
ii
present
elev
level
cyclin
promot
cell
produc
may
result
upregul
transcript
cyclin
turn
may
respons
acceler
cell
cycl
cell
addit
consequ
abund
nuclear
like
focu
futur
studi
determin
whether
product
result
upregul
growth
cell
type
transfect
monocyt
hela
cell
plasmid
use
attracten
reagent
alongsid
attractenetr
control
plasmid
day
cell
analyz
differ
viabil
data
figur
show
transfect
littl
effect
cell
wherea
hela
cell
significantli
increas
viabil
next
explor
effect
product
primari
cell
pbmc
transfect
day
attracten
reagent
follow
analysi
cell
viabil
result
figur
show
one
repres
pbmc
sampl
well
pool
data
pbmc
test
biolog
triplic
pbmc
pbmc
test
increas
cellular
viabil
observ
upon
transfect
comparison
controltr
cell
collect
data
point
increas
rate
growth
cell
type
includ
primari
cell
therebi
potenti
indic
cell
typedepend
effect
growth
regul
previous
show
exosom
cell
enrich
specif
marker
alix
wherea
donor
cell
contain
higher
level
escrt
protein
therefor
ask
whether
alter
cell
cycl
dynam
donor
cell
could
impact
ev
product
control
cell
block
stage
cell
cycl
analyz
level
escrt
protein
exosom
marker
figur
sidebysid
analys
ev
content
ach
activ
exosom
produc
cell
cycl
block
cell
likewis
perform
figur
c
data
figur
show
interestingli
unsynchron
control
cell
drastic
differ
escrt
protein
level
compar
control
cell
figur
compar
lane
vs
consist
previou
find
level
alix
also
increas
unsynchron
cell
addit
cell
greater
abund
modifi
form
b
glycosyl
unsynchron
moreov
control
cell
contain
distinct
pattern
band
kda
resembl
cell
phase
function
signific
larger
form
current
uncertain
chang
also
present
increas
level
alix
compar
cell
figur
compar
lane
vs
chang
cell
phase
less
drastic
minor
differ
collect
data
indic
cell
may
differ
cell
cycl
dynam
compar
control
cell
particularli
result
alter
pattern
escrt
protein
exosom
marker
analysi
exosom
marker
cell
cycleblock
cell
ev
reveal
increas
form
compar
cell
figur
test
ach
activ
indic
exosom
abund
total
number
exosom
unsynchron
control
vs
cell
significantli
differ
figur
howev
interest
note
number
exosom
reduc
log
compar
unsynchron
control
exosom
cell
type
find
corrobor
distinct
reduct
escrt
figur
exosom
protein
compar
level
phase
figur
b
cell
type
similar
level
exosom
produc
block
compar
unsynchron
control
cell
howev
cell
produc
significantli
exosom
compar
control
wherea
cell
addit
cell
produc
significantli
fewer
exosom
phase
compar
cell
phase
figur
togeth
result
suggest
exosom
ev
produc
cell
cycledepend
manner
cell
phase
produc
significantli
fewer
vesicl
moreov
cell
produc
may
alter
pattern
cell
cycledriven
exosom
product
demonstr
differenti
pattern
escrt
exosom
marker
protein
express
next
wish
close
examin
effect
cell
cycl
block
ev
product
cell
produc
low
high
level
cell
block
phase
day
follow
harvest
cell
cultur
supernat
filtrat
analysi
result
ev
zetaview
data
figur
display
peak
diamet
size
mode
vesicl
releas
cell
significantli
larger
vesicl
produc
compar
cell
wherea
cell
larger
ev
block
phase
also
untreat
cultur
compar
cell
addit
larger
vesicl
produc
cell
type
comparison
untreat
control
although
differ
consist
signific
overal
trend
regard
ev
concentr
vesicl
cell
decreas
number
leveldepend
manner
compar
cell
group
figur
furthermor
amongst
cell
type
number
ev
present
phase
significantli
reduc
unsynchron
control
cultur
find
support
earlier
conclus
exosom
may
produc
lower
level
cell
rest
figur
c
note
zetaview
analysi
detect
total
number
vesicl
larg
particl
present
exosom
compris
fraction
therefor
determin
distribut
true
exosom
contain
use
previous
publish
strategi
exosom
character
densiti
gradient
ultracentrifug
methodolog
shown
possibl
clearli
separ
exosom
potenti
contamin
viral
particl
thu
make
detail
character
specif
ev
popul
possibl
grew
control
cell
day
harvest
supernat
incub
unfilt
supernat
exomax
follow
separ
result
extracellular
materi
iodixanol
densiti
gradient
fraction
fraction
subject
western
blot
analysi
exosom
marker
protein
result
figur
show
cell
exosom
fraction
fell
distinct
categori
first
fraction
contain
high
level
moder
level
previou
public
classifi
group
true
exosom
distinct
viral
particl
apoptot
bodi
second
fraction
present
moder
amount
wherea
level
increas
popul
also
consist
exosom
categori
contain
viral
particl
demonstr
previou
public
although
case
group
like
exosom
larger
size
dens
smaller
one
seen
fraction
final
fraction
show
distinct
reduct
drastic
increas
actin
like
larger
denser
vesicl
true
exosom
either
microvesicl
apoptot
bodi
contrast
cell
notic
differ
distribut
exosom
marker
although
distinct
popul
still
present
figur
fraction
almost
absent
although
still
present
higher
amount
compar
background
addit
shift
right
major
popul
fraction
ev
fraction
observ
final
popul
high
level
low
level
seen
fraction
similar
cell
protein
although
present
fraction
variou
extent
seen
enrich
vesicl
popul
especi
fraction
abund
fraction
like
due
presenc
vlp
beecaus
filtrat
supernat
vesicl
enrich
fraction
experi
altogeth
result
suggest
cell
produc
releas
fewer
ev
slightli
larger
size
cell
gener
releas
significantli
fewer
although
larger
exosom
furthermor
outsid
vlp
virion
releas
ev
primarili
exosom
consist
previou
observ
may
also
releas
larger
vesicl
potenti
free
protein
within
protein
complex
rational
util
filter
experi
base
upon
knowledg
ebola
virion
vlp
commonli
size
larger
rare
straight
therefor
abl
effect
pass
filter
fact
beniac
et
al
previous
show
approxim
infecti
virion
nm
length
virion
occur
multipl
size
smaller
virion
contain
complet
genom
observ
investig
virion
electron
microscopi
hand
ev
exosom
nm
diamet
abl
pass
filtrat
downstream
analysi
test
concept
use
vlp
contain
np
gp
ebov
protein
simpl
filtrat
vlp
spike
ml
pb
shown
supplementari
figur
alongsid
filter
pb
alon
mock
unfilt
vlp
control
filter
sampl
incub
particl
process
western
blot
analysi
ebov
protein
result
indic
filtrat
vlp
small
volum
drastic
reduc
level
ebov
protein
present
undetect
level
next
character
distribut
vlp
comparison
ev
size
spike
vlp
ml
supernat
vlpspike
supernat
either
filter
left
unfilt
incub
vesicleenrich
agent
exomax
result
materi
load
top
qev
izon
size
exclus
column
fraction
collect
correspond
column
void
volum
fraction
no
known
contain
vesicl
larger
nm
diamet
fraction
no
fraction
next
incub
particl
concentr
materi
follow
western
blot
analysi
viral
protein
exosom
marker
actin
result
supplementari
figur
show
unsurprisingli
protein
origin
unfilt
vlp
mostli
appear
first
fraction
void
volum
column
fraction
overlap
next
fraction
shown
strong
presenc
np
gp
particularli
larger
glycosyl
form
gp
low
level
actin
observ
present
control
vlp
present
ev
supplementari
figur
compar
lane
lane
howev
upon
filtrat
approxim
ebov
protein
vanish
fraction
number
sizeabl
reduct
level
gp
np
fraction
number
notabl
np
origin
vlp
elimin
fraction
filtrat
anoth
interest
observ
center
around
visibl
form
gp
specif
unfilt
fraction
higher
fraction
number
correspond
smaller
vesicl
larger
glycosyl
form
gp
decreas
level
lower
molecular
weight
form
gp
increas
filter
fraction
glycosyl
larger
form
gp
present
low
level
wherea
lower
molecular
weight
gp
level
rel
high
comparison
vlp
control
lane
predomin
form
gp
present
glycosyl
form
togeth
result
suggest
glycosyl
gp
may
princip
form
within
vlp
wherea
lower
molecular
weight
form
gp
may
like
associ
ev
collect
data
may
indic
vlp
appear
mainli
larger
fraction
number
lesser
extent
fraction
number
wherea
ev
true
exosom
present
fraction
number
previous
shown
exosom
transfect
cell
contain
vitro
knowledg
never
shown
present
ev
context
full
viral
infect
address
infect
huvec
ebovkik
moi
contain
day
follow
harvest
supernat
filtrat
incub
exomax
enrich
vesicl
load
onto
qev
size
exclus
column
fraction
number
collect
incub
particl
analyz
western
blot
ebov
protein
np
gp
actin
result
figur
demonstr
np
gp
present
ev
concentr
ebovinfect
cell
addit
ebov
protein
observ
highli
concentr
fraction
number
follow
close
fraction
number
shown
fraction
ev
exosom
appear
supplementari
figur
np
also
present
fraction
number
wherea
gp
present
low
level
fraction
possibl
fraction
may
repres
slightli
larger
vesicl
incorpor
gp
protein
much
less
abund
fraction
number
contain
smaller
vesicl
actin
follow
similar
trend
actin
present
fraction
number
littl
detect
protein
present
fraction
number
collect
result
indic
gp
np
also
packag
vesicl
cell
activ
infect
ebov
take
one
step
next
use
inactiv
nhp
serum
sampl
infect
macaqu
uninfect
preble
anim
inactiv
sampl
filter
ev
concentr
particl
sampl
analyz
western
blot
level
exosom
protein
data
figur
show
exosom
nhp
serum
sampl
concentr
demonstr
presenc
tetraspanin
addit
appear
fairli
high
level
serum
sampl
infect
anim
quantit
densitometri
use
calcul
approxim
amount
present
cell
ev
much
releas
infect
nhp
sampl
cell
releas
approxim
ng
evassoci
wherea
nhp
nhp
releas
ng
evassoci
serum
respect
addit
determin
compos
averag
approxim
purifi
vlp
contain
gp
np
data
shown
interest
note
present
nhp
serum
succumb
infect
sooner
day
vs
day
whose
serum
collect
earlier
time
point
infect
comparison
nhp
day
vs
day
therefor
result
indic
present
ev
vivo
ebov
infect
higher
level
potenti
preval
earlier
time
point
robust
infect
although
western
blot
confirm
presenc
captur
exosom
certain
captur
ev
free
protein
analysi
nhp
sampl
therefor
rule
may
present
exosom
also
combin
ev
andor
free
protein
vivo
taken
togeth
result
indic
rel
high
level
np
present
ev
cell
infect
ebov
vitro
vivo
evd
bystand
cell
mainli
die
apoptosi
wherea
monocytesmacrophag
appear
die
necrosi
previous
shown
ev
cell
induc
death
recipi
immun
cell
therefor
test
abil
recipi
cell
withstand
low
versu
high
level
evassoci
incub
cem
jurkat
cell
filter
supernat
cell
follow
measur
cell
viabil
day
later
result
figur
show
cem
jurkat
cell
similar
reduct
cellular
viabil
treatment
supernat
cell
howev
treatment
monocyt
supernat
line
show
dosedepend
reduct
cellular
viabil
data
suggest
cell
equal
sensit
low
high
level
extracellular
wherea
monocyt
sensit
higher
dose
evassoci
interest
note
cell
incub
supernat
cell
cell
show
signific
increas
viabil
potenti
indic
celltyp
depend
mechan
cell
death
induct
evassoci
mechan
cell
death
condit
previous
explor
along
line
incub
recipi
cem
jurkat
cell
monocyt
increas
concentr
ev
cell
ev
control
cell
ev
cell
type
produc
absenc
western
blot
perform
cell
death
marker
includ
caspas
data
figur
show
treatment
increas
concentr
ev
cell
induc
cell
death
apoptosi
shown
cleavag
caspas
recipi
cell
monocyt
phenotyp
observ
cell
ev
treatment
ev
cell
type
note
high
level
ev
cell
stimul
low
level
cleavag
cell
type
howev
cleavag
caspas
detect
togeth
data
indic
ev
cell
caus
death
apoptosi
recipi
cell
monocyt
cell
kept
constant
antibiot
select
wish
verifi
induct
cell
death
recipi
cell
due
residu
hygromycin
b
within
supernat
therefor
cell
grown
day
exosomefre
media
follow
harvest
supernat
filtrat
ultracentrifug
result
ev
pellet
resuspend
steril
pb
use
treat
recipi
cem
cell
increas
concentr
cell
treat
day
follow
analysi
cell
viabil
data
figur
show
comparison
cem
cell
treat
highest
concentr
ev
particlescel
signific
dosedepend
decreas
recipi
cell
viabil
treat
purifi
ev
cell
find
verifi
ev
cell
neg
impact
recipi
immun
cell
given
previou
character
ev
cell
comparison
cell
figur
next
wish
determin
ev
fraction
respons
induct
cell
death
recipi
cell
supernat
cell
harvest
separ
iodixanol
gradient
follow
pool
select
fraction
cell
type
pool
fraction
chosen
cell
group
highest
level
exosom
marker
pool
fraction
dilut
steril
pb
subject
second
ultracentrifug
spin
isol
ev
away
residu
iodixanol
result
ev
pellet
resuspend
pb
use
treat
recipi
cem
cell
concentr
particlescel
day
follow
analysi
cell
viabil
treatment
ev
fraction
cell
result
signific
decreas
viabil
cem
cell
comparison
treat
ev
fraction
figur
hand
cell
treat
fraction
either
cell
type
differ
viabil
collect
data
may
signifi
ev
within
fraction
cell
induc
cell
death
recipi
immun
cell
data
show
ev
cell
capabl
caus
apoptosi
recipi
immun
cell
figur
biogenesi
ev
potenti
tie
regul
cell
cycl
figur
furthermor
demonstr
acceler
cell
cycl
potenti
driven
upregul
cyclin
nuclear
figur
therefor
next
investig
util
inhibitor
fascaplysin
ribociclib
fdaapprov
reduc
ev
product
cell
cell
treat
day
increas
concentr
fascaplysin
ribociclib
follow
analysi
cell
viabil
ev
concentr
cell
treat
low
level
either
inhibitor
number
ev
releas
significantli
decreas
howev
increas
concentr
drug
product
vesicl
increas
dosedepend
manner
figur
result
may
due
toxic
drug
high
level
viabil
cell
significantli
decreas
increas
dose
either
drug
figur
specif
low
level
inhibitor
cell
may
result
block
cell
cycl
therebi
result
lower
level
ev
releas
wherea
higher
level
drug
may
becom
toxic
result
increas
releas
vesicl
contrast
cell
show
significantli
decreas
level
ev
product
dose
fascaplysin
although
highest
dose
ev
product
decreas
less
significantli
comparison
lowest
dose
test
figur
ev
reduct
occur
despit
signific
decreas
cell
viabil
cell
figur
ribociclib
treatment
cell
show
less
signific
result
compar
fascaplysin
treatment
highest
dose
result
signific
reduct
ev
number
cellular
viabil
figur
b
togeth
result
suggest
fascaplysin
treatment
result
fewer
ev
cell
compar
cell
higher
dose
although
high
dose
also
result
signific
decreas
viabil
cell
type
addit
ribociclib
treatment
may
impact
cell
viabil
ev
biogenesi
cell
less
cell
indic
cell
react
inhibitor
similar
way
cell
hint
drug
may
impact
cell
cycl
regul
ev
biogenesi
pathway
distinctli
differ
way
although
mechan
action
fascaplysin
current
uncharacter
ribociclib
known
interact
directli
molecul
atp
pocket
futur
studi
diverg
mechan
use
drug
may
interact
pathway
modul
may
potenti
advantag
determin
potenti
therapeut
util
inhibitor
infect
previous
show
exosom
cell
capabl
induc
cell
death
recipi
cell
monocyt
also
confirm
mechan
cell
death
apoptosi
figur
along
line
attempt
gain
insight
protein
contain
exosom
may
potenti
point
mechan
induct
cell
death
recipi
cell
cell
cultur
day
exosomefre
media
supernat
harvest
filter
incub
exomax
enrich
ev
sampl
load
onto
optiprep
iodixanol
gradient
fraction
harvest
use
chose
fraction
previou
public
shown
fraction
specif
enrich
exosom
fewer
contamin
vesicl
viral
particl
fraction
incub
particl
process
analysi
tandem
mass
spectra
data
present
supplementari
tabl
show
protein
significantli
upregul
ev
protein
score
fraction
cell
type
summat
overal
interest
trend
glean
number
protein
identifi
sampl
fraction
cell
detect
protein
respect
potenti
show
overal
decreas
number
protein
present
increas
product
level
data
shown
howev
fraction
opposit
trend
seen
ev
protein
identifi
respect
data
shown
result
could
potenti
indic
total
number
ev
shift
fraction
toward
fraction
cell
wherea
cell
possibl
possess
ev
fraction
comparison
data
support
previou
conclus
ev
cell
shift
toward
right
ie
dens
figur
therefor
may
contain
greater
divers
quantiti
cargo
presenc
heat
shock
protein
hsp
heat
shock
cognat
seen
abund
across
cell
type
indic
sampl
contain
exosom
larg
increas
number
protein
relat
rna
bind
seen
increas
level
specif
numer
rna
bind
protein
includ
heterogen
nuclear
ribonucleoprotein
found
ev
cell
wherea
detect
cell
ev
addit
sever
deadbox
protein
ddx
type
helicas
shown
upregul
ev
cell
categori
interest
upregul
presenc
includ
addit
vesicleassoci
translationassoci
nuclear
transcriptionassoci
proteasom
cell
deathrel
protein
transport
rna
splice
protein
particular
interest
cytokin
vascular
endotheli
growth
factor
vegf
transform
growth
factor
precursor
insulinlik
growth
factor
ii
igfii
correspond
bind
protein
latenttransform
growth
factor
betabind
protein
precursor
insulinlik
growth
factorbind
protein
precursor
found
present
ev
well
document
erupt
cytokin
cytokin
storm
often
accompani
fatal
case
ebov
infect
specif
cytokin
includ
granulocytemacrophag
colonystimul
factor
gmcsf
growthregul
oncogen
gro
interferon
ifn
ifninduc
eotaxin
monocyt
chemoattract
protein
mcp
macrophageinflammatori
protein
mip
macrophag
colonystimul
factor
mcsf
rant
vegf
implic
differenti
downregul
ebov
pathogenesi
led
us
question
whether
addit
cytokin
could
potenti
present
upregul
exosom
ev
end
filter
supernat
pool
exosom
fraction
cell
run
sidebysid
human
cytokin
array
filter
exosomefre
dmem
media
also
use
control
densitometri
perform
cytokin
count
dmem
background
level
graph
supplementari
figur
supernat
cytokin
rant
epiderm
growth
factor
egf
oncostatin
present
higher
level
cell
compar
cell
supplementari
figur
contrast
cell
supernat
slightli
enrich
sever
differ
cytokin
gro
howev
cytokin
enrich
exosom
fraction
analyz
increas
almost
cytokin
level
observ
compar
seen
whole
supernat
supplementari
figur
vs
particular
exosom
possess
higher
level
gro
mcsf
mig
tarc
egf
oncostatin
lower
amount
leptin
compar
exosom
addit
cytokin
undetect
whole
supernat
found
exosom
sampl
includ
mcsf
macrophagederiv
chemokin
mdc
stem
cell
factor
scf
angiogenin
plateletderiv
growth
factor
pdgf
bb
leptin
find
could
potenti
due
select
enrich
workflow
concentr
cytokineassoci
exosom
much
higher
whole
supernat
sampl
therefor
easili
detect
assay
cytokin
granulocyt
colonystimul
factor
gcsf
gmcsf
mdc
rant
scf
angiogenin
thrombopoietin
vegf
pdgf
bb
present
exosom
similar
level
interest
note
exosom
cell
type
shown
possess
vegf
support
ms
result
supplementari
tabl
collect
data
indic
ev
specif
exosom
cell
may
contain
divers
set
uniqu
upregul
protein
addit
plethora
cytokin
associ
vesicl
releas
viral
affect
healthi
host
cell
moreov
specif
cytokin
may
concentr
within
ev
cell
produc
may
potenti
play
role
cytokin
storm
associ
pathogenesi
ebov
induct
cell
death
recipi
immun
cell
poor
outcom
infect
individu
previous
show
ebov
becom
incorpor
exosom
therebi
neg
impact
recipi
cell
monocyt
line
addit
shown
vesicl
induc
cell
death
apoptosi
recipi
cell
figur
cell
death
exacerb
monocyt
treat
ev
cell
produc
higher
level
hand
ev
cell
produc
low
high
level
equal
destruct
cell
bystand
tcell
death
apoptosi
one
hallmark
evd
especi
fatal
case
furthermor
determin
ev
sediment
within
fraction
iodixanol
densiti
gradient
abl
significantli
reduc
recipi
tcell
death
ev
fall
fraction
figur
find
may
noteworthi
believ
fraction
mainli
contain
apoptot
bodi
larg
microvesicl
vlp
case
cell
thu
potenti
indic
extracellular
particl
may
signific
contributor
overal
decreas
health
recipi
immun
cell
therefor
ev
intermedi
densiti
may
compris
potenti
mechan
bystand
immun
cell
apoptosi
evd
interestingli
contrast
immun
cell
human
embryon
kidney
epitheli
cell
treat
ev
low
high
cell
show
increas
cell
viabil
could
potenti
due
cell
typedepend
mechan
action
recipi
cell
vesicl
addit
cell
may
altogeth
resist
ev
compon
respons
cell
death
immun
cell
may
convers
posit
stimul
vesicl
studi
specif
compon
respons
phenotyp
recipi
cell
need
resist
certain
cell
type
could
quit
signific
context
infect
monocyt
macrophag
dendrit
cell
first
sustain
target
ebov
cell
die
rel
earli
infect
howev
epitheli
endotheli
cell
also
product
infect
viru
albeit
later
time
point
infect
uninfect
nonimmun
cell
endotheli
epitheli
bombard
vesicl
contain
viral
compon
earli
infect
possibl
recipi
cell
may
stimul
prime
futur
infect
type
mechan
seen
case
tar
exosom
contain
viral
rna
predispos
recipi
cell
recept
infect
type
pathogen
process
take
place
inhibit
vesicl
biogenesi
infect
cell
explor
determin
potenti
benefit
recipi
cell
determin
pathway
contribut
ev
biogenesi
donor
cell
investig
cell
cycl
cell
rational
experi
cell
contain
replic
faster
control
cell
lead
us
ask
whether
cell
cycl
pattern
affect
explor
differ
cell
cycl
dynam
clone
import
note
although
vector
origin
replic
cell
contain
tantigen
possibl
time
copi
plasmid
integr
host
genom
cell
rec
allow
recombin
howev
observ
differ
clone
attribut
dose
respons
product
cell
cycl
effect
cell
observ
alter
cell
cycledepend
manner
exosom
biogenesi
pathway
compon
escrt
protein
also
morpholog
growth
pattern
ev
content
abund
figur
moreov
cell
exhibit
increas
level
cyclin
protein
activ
figur
cyclin
well
describ
cell
cycl
regul
potenti
oncogen
known
upregul
sever
cancer
addit
cyclin
previous
shown
produc
elev
level
result
mani
viral
infect
especi
known
caus
cancer
although
ebov
shown
result
higher
incid
cancer
survivor
possibl
phenotyp
may
transient
one
effect
brief
time
virul
factor
replic
viru
result
infect
cell
death
ebov
shown
best
thrive
activ
grow
cell
upregul
cyclin
may
simpli
strategi
use
viru
aid
replic
howev
larger
proport
recurr
persist
asymptomat
ebov
infect
come
light
studi
increas
number
ebov
survivor
signific
topic
concern
potenti
lead
transmiss
viru
futur
outbreak
viru
manag
remain
long
term
within
human
nhp
host
yet
conclus
determin
howev
viral
persist
replic
within
monocyt
macrophag
cell
type
detect
within
brain
eye
test
nhp
survivor
infect
central
nervou
systemresid
myeloid
cell
also
dysregul
cell
cycl
could
potenti
repres
method
use
ebov
counteract
cytotox
support
prolong
viral
replic
latenc
previou
studi
shown
transient
present
nucleu
infect
cell
earli
time
point
shown
present
rel
high
level
within
nucleu
stabli
transfect
cell
found
larg
proport
cyclin
promot
figur
may
possibl
earli
infect
transloc
nucleu
may
serv
role
transcript
regul
host
gene
best
benefit
viru
likelihood
nuclear
action
transcript
regul
limit
cyclin
gene
investig
direct
interact
farreach
effect
nucleu
could
vital
import
elucid
molecular
basi
ebov
pathogenesi
host
cell
cell
cycl
dysregul
cell
also
result
alter
pattern
ev
biogenesi
figur
interest
cell
test
produc
significantli
fewer
ev
also
larger
unsynchron
control
mani
eukaryot
cell
quiescent
normal
healthi
vivo
environ
could
repres
import
trend
inher
differenti
ev
cell
frequent
divid
versu
activ
replic
cancer
cell
result
also
show
ev
cell
gener
fewer
number
denser
larger
size
figur
larger
vesicl
higher
densiti
would
impli
enrich
cargo
within
ev
support
greater
abund
protein
detect
ms
analysi
supplementari
tabl
increas
number
divers
protein
found
ev
cell
could
influenc
outcom
recipi
cell
particularli
protein
associ
nucleic
acid
collect
rnabind
protein
found
ms
analysi
ev
cell
although
yet
know
rna
associ
protein
may
import
activ
recipi
cell
assort
cytokin
also
found
upregul
seen
ev
supplementari
figur
abl
detect
cytokin
elev
level
exosom
prepar
cell
may
indic
stimul
product
potenti
direct
indirect
target
nuclear
transcript
regul
moreov
fact
abl
detect
cytokin
exosom
prep
cell
type
signific
find
studi
major
cytokin
test
enrich
exosom
compar
whole
supernat
case
vivo
vesicl
heavili
laden
cytokin
origin
infect
cell
could
act
cytokin
bomb
recipi
immun
cell
way
ev
singl
diseas
cell
would
abl
enact
devast
effect
recipi
cell
may
also
substanti
import
mani
viral
inflammatori
diseas
cytokin
play
inflammatori
damag
role
due
observ
upregul
cyclin
protein
activ
also
explor
abil
ribociclib
fascaplysin
inhibit
activ
therebi
slow
releas
vesicl
cell
cycledriven
manner
cell
figur
result
show
fascaplysin
abl
significantli
decreas
number
vesicl
produc
cell
low
nontox
dose
contrast
ribociclib
abl
decreas
level
ev
produc
cell
dose
affect
cell
viabil
differ
cell
respons
inhibitor
suggest
cell
may
less
suscept
effect
ribociclib
futur
mechanist
studi
molecular
action
drug
connect
may
elucid
potenti
therapeut
util
direct
drug
target
previous
show
ebov
packag
exosom
cell
show
found
within
ev
isol
vitro
vivo
wildtyp
ebov
infect
figur
b
furthermor
ev
ebovinfect
cell
contain
np
gp
protein
viru
np
respons
encapsid
rna
genom
viru
soon
synthes
format
nucleocapsid
conjunct
viral
protein
np
main
viral
protein
respons
bind
rna
genom
np
bound
base
rna
presenc
np
within
ev
could
also
potenti
hint
presenc
bound
viral
rna
within
ev
well
hand
gp
sole
surfac
protein
ebov
import
viral
entri
egress
gp
also
implic
pathogenesi
gp
shown
cytotox
effect
infect
cell
furthermor
solubl
gp
found
larg
quantiti
blood
infect
patient
propos
potenti
play
role
immun
evas
absorpt
neutral
antibodi
experi
involv
filtrat
vlp
follow
size
exclus
separ
extracellular
materi
show
vlp
abl
remov
sampl
filtrat
wherea
smaller
vesicl
vlp
prepar
contain
ebov
protein
abl
pass
filtrat
supplementari
figur
result
also
interestingli
hint
toward
potenti
role
gp
ev
unfilt
vlp
show
enrich
primarili
glycosyl
gp
fraction
correspond
larger
vesicl
fraction
number
wherea
filter
vlp
show
mainli
lower
molecular
weight
form
gp
coloc
exosom
marker
therefor
ev
stud
gp
protein
could
form
addit
previous
unknown
sourc
immun
subvers
viral
mask
use
ebov
presenc
viral
protein
rna
ev
explor
analyz
futur
studi
conclus
show
dysregul
cell
cycl
donor
cell
transloc
nucleu
upregul
function
cyclin
protein
turn
cell
cycl
shown
regul
ev
biogenesi
extracellular
vesicl
cell
also
alter
content
includ
rnabind
protein
cytokin
import
ebov
pathogenesi
addit
np
gp
protein
detect
within
ev
ebovinfect
cell
collect
cell
cyclerel
effect
within
donor
cell
may
repercuss
virul
replic
effici
ebov
upregul
packag
protein
ev
overal
outcom
evrecipi
cell
infect
individu
